Xiangyu Gao

9PUBLICATIONS
47CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markersCancer cell biologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 27, 2025
Author Correction: First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial.

Lin Shen, Yanqiao Zhang, Ziyu Li

|Jan 22, 2025
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial.

Lin Shen, Yanqiao Zhang, Ziyu Li

|Sep 17, 2024
CD24-Targeted NIR-II Fluorescence Imaging Enables Early Detection of Colorectal Neoplasia.

Xiaoyong Guo, Shuangling Luo, Xiaofeng Wang

|May 22, 2024
Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trial.

Xiangyu Gao, Ke Ji, Yongning Jia

|Aug 12, 2023
Using Normalized Carcinoembryonic Antigen and Carbohydrate Antigen 19 to Predict and Monitor the Efficacy of Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer.

Xiao-Huan Tang, Xiao-Long Wu, Xue-Jun Gan

|Oct 27, 2022
Clinical Significance and Immune Infiltration Analyses of the Cuproptosis-Related Human Copper Proteome in Gastric Cancer.

Xiaohuan Tang, Ting Guo, Xiaolong Wu

Pageof 2

Frequent Collaborators

5 joint publications

Ziyu Li

5 joint publications

Jiafu Ji

3 joint publications

Lin Shen

3 joint publications

Zhongmin Maxwell Wang